WILLIAMSVILLE – February 8, 2018 – Windsong’s mobile mammography is now driving early detection throughout Western New York. As a provider of mobile breast cancer screening, Windsong now has the ability to eliminate barriers to breast cancer screening in communities with limited or no access to breast cancer screening. Its first event held at Mercy Comprehensive Care in Buffalo provided 22 women with access to this life saving exam. […]
Williamsville, January 31, 2018 — Dr. Cynthia Fan will present the findings from a retrospective study conducted by Windsong and Windsong Breast Care at the 28 th Annual Interdisciplinary Breast Center (NCBC) Conference this March. The study shows that 3D tomosynthesis (3D mammomgraphy) detects smaller cancers, and more cancers with architecture distortions, which can be very difficult to see in 2D digital mammography (Mammo) only. Corresponding author, Cynthia Fan, MD, PhD said, “This project was designed to demonstrate how tomosynthesis (tomo) assists with tumor detection, whether through smaller tumor size or any particular imaging characters. […]
Dr. Dana Dunleavy, Director of Windsong Vein Care at Windsong’s Williamsville location, treats patients with the image-guided minimally invasive VenaSeal Closure system. According to Dr. Dunleavy this treatment is a big improvement in endovascular vein treatment because it is more comfortable, better tolerated, and offers rapid recovery times with no activity restrictions. Learn more in the article titled Improved Treatment Options in Endovascular Vein Treatment, written by Julie Nusbaum in Volume 5 for 2017.
In partnership with WGRZ, we invite you to Become an Early Detection Champion!
A great big thank you to all who participated in this year’s Komen Race for the Cure. Participants ranged from Windsong volunteered, walked, ran, and donated. We had the largest team with 169 participants. Collectively the Windsong Breast Care team raised over $5000 this year. Many thanks to all who joined us this year. See you next year!
Please join us in welcoming Maria Komissarova, MD to our team of experienced radiologists. To read more about Dr. Komissarova and other Windsong news, click here.
Thanks for joining the Windsong at the May 4th It Takes 2 Event!
Patients and their Doctors are choosing wisely
In today’s healthcare environment of high deductibles and growing co-pays, referring providers and patients alike are cautiously choosing providers of care, with cost in mind. Windsong has long been offering a number of treatments in its minimally invasive procedure clinic that are far more affordable when compared to the same service provided in the hospital or ambulatory surgery center.
When considering just patient co-pays, specialist office visits for procedures typically require a $30-50 co-pay compared to the hospital or ambulatory surgery co-pay of $100-500. Hospital charges can be even higher. This savings can be especially significant for patients that must undergo multiple procedures, some of which are noted below.
- Mediport placement
In comparison, some in-offi ce procedures done at Windsong can be up to 50% more cost effective than those performed in other surgical center or hospital settings.
Today’s value-based reimbursement models highly encourage a reduction in wasteful healthcare dollars. Cost effectiveness cannot be the only factor considered, and Windsong takes great pride in ensuring the right procedure is done on the right patient at the right time, with strong quality controls that lead to the most cost effective outcomes for our patients.
Windsong’s Interventional Radiology clinic can be reached at 716.929.9484
NY MAMMOGRAPHY ACCESS BILL EFFECTIVE
Women in New York now have an easier time getting a mammogram thanks to Gov. Cuomo’s legislation which expands access to breast cancer screening. This law, which went into effect on January 1, is the most aggressive breast screening legislation in the country and mandates extended screening hours for hospitals and eliminates deductibles and copayments for all screening and most diagnostic imaging.
Many women delay their annual mammograms because of concern over cost and this removes that barrier. Co-pays for all screening mammograms will be eliminated for most diagnostic imaging. Patients across WNY can rest assured that they will no longer incur additional out-ofpocket expenses for common
diagnostic imaging. Dr. Anna Chen, director of women’s imaging at Windsong, said, “Governor Cuomo’s initiatives will increase the chances of early detection. Thanks to this groundbreaking legislation earlier and more effective treatments will save lives.”
The new mandate requires NY administered health plans to cover screening and diagnostic mammograms, screening and diagnostic tomosynthesis (3D mammography), breast ultrasounds, and breast MRIs, with no co-pay, coinsurance, or for patients. While this legislation will cover a vast majority of our patients, it is unclear how Medicare, self-funded and out of area health plans will be handling exams.
As you can see, there will be a number of women who will not have the coverage that the regulation implies. Windsong will work closely with all of your
underinsured patients, and connect them to Cancer Services Program, should the need arise.
CORRECTLY CODING FOR DEXA SCREENING
Practices using EMRs often mistakenly choose the first Dexa bone density code when searching through their EMR. All providers ordering screening bone density exams should use the following code:
- Bone density CPT code 77080
If there is suspicion of a fracture, you may use the following:
- Fracture assessment or lateral vertebral fracture CPT Code 77082
Approximately 12 million Americans older than 50 years have osteoporosis and 50% of all postmenopausal women will have an osteoporosis-related fracture during their lifetime; 25% will develop a vertebral deformity; 15% will experience a hip fracture.
Who Should Have a Bone Density Test?
National Osteoporosis Foundation recommends bone density tests for:
- Women age 65 or older
- Men age 70 or older
- Anyone who has broken bone after age 50
- Women of menopausal age with risk factors
- Postmenopausal women under age 65 with risk factors
- Men age 50-69 with risk factors
A bone density test may also be necessary if patients have any of the following:
- X-Ray demonstrates a patient’s spine has a break or bone loss
- Patient presents with back pain with a possible spine fracture
- Patient has had height loss of ½ inch or more within one year
- Patient has had total height loss of 1½ inches from your original height
If you would like to learn more about bone density testing, please visit the National Osteoporosis Foundation website at https://nof.org/
To schedule an appointment, please call (716) 631-2500.
HAPPY 30TH ANNIVERSARY WINDSONG
This month marks the 30th anniversary of Windsong. If you don’t know the story, it is a remarkable one. It all began when John and Janet Sung moved from South Korea to America as newlyweds in 1972, arriving in New Jersey with only $200 in their pockets.
On a snowy February morning in 1987 they opened their new radiology practice in a renovated 2,000 square foot Pizza Hut building on Harlem Road. Dr. Sung pioneered face to face results and wanted more for her patients. After a tour of the Mayo Clinic they vowed to create their own version of patient centered imaging. They purchased 6 acres of vacant land on Spindrift in May of 1992, and embarked on making their dream come true.
Awards for clinical excellence, business success and community leadership were abundant over the years. In 1999, Dr. Sung and John Sung established the John and Janet Sung Scholarship Endowment Fund, donating $1 million to the U.B. Medical School.
The Sungs are enjoying a well deserved retirement while Windsong continues to grow – currently employing 19 Radiologists, 2 Breast Surgeons, Nurse Practitioners and Physician Assistants, as well as 270 team members. Its growth is attributed to three things: putting the patient first, working with the latest medical technologies, and continually attracting and retaining the best physicians and team members. Congratulations Windsong!
LOW DOSE LUNG CANCER SCREENING FOLLOW UP AUTHORIZATION
There has been some confusion around how to code for the low dose lung cancer screening follow up exams. Patients only qualify for a fully covered low dose lung cancer CT exam once per year under code G0297. Any 3, 6 or 9 month follow up exam recommendation after the initial low dose CT should be coded 71250 for authorization.
NEW ACCREDITATION ENABLES ALZHEIMER’S RESEARCH
Windsong has been granted PET Brain Accreditation from the American College of Radiology. Up until now, like most PET facilities, Windsong was only accredited for oncology PET. Adding on the Brain module enables Windsong to participate in a number of Alzheimers’ research studies, and paves the way for future diagnostic PET Amyloid imaging once the amyloid isotope becomes available locally.
Windsong joins just one other Buffalo and two other facilities in the Rochester area to carry this distinction. There are only a few in Syracuse, Utica, and Albany with this unique extended accreditation in PET/CT.
GENETIC COUNSELING FAQ
Genetic counseling is quickly being sought after. Windsong’s certified genetic counselor, Laura Fisher, cautions patients about having genetic testing without the appropriate counseling. “Patients must be prepared to understand the implications,” said Fisher. Genetic counseling ensures the right person in the family is tested, the right genetic test is ordered, and the right laboratory is used.
Genetic counseling and testing may be considered for individuals with a personal or strong family history of cancer. Frequently asked questions include:
- How much does genetic testing cost? Many insurance carriers cover genetic testing as a preventive service, meaning many patients pay $0, if they qualify.
- How much does a visit with a genetic counselor cost? The cost to the patient is similar to the cost of visiting any other specialist.
- How long does an appointment with a genetic counselor last? About 1 hour.
- What kind of genetic testing does Windsong offer? Cancer genetic testing related to a personal or family history of any type(s) of cancer.
- How do we refer a patient? Patients can call 626-6300 to schedule an appointment.
- What models are used to calculate lifetime breast cancer risk? After a genetic counseling appt, our genetic counselor has access to 4 different models. The final report will include the range of breast cancer risks based on the different models.
If your patients had genetic testing just a few years ago, they may be eligible for additional testing of newly recognized genes. Today there are nearly 50 genes that can be tested, compared to the BRCA 1 and BRCA 2 genes that many are more familiar with. To learn more, visit windsonghealth.com or call 716.626.6300.
C-VIEW™ SOFTWARE AND PERSONALIZED SCREENING: UNPARALLELED EXPERIENCE MATTERS
As we all know, breast cancer screening has the ability to detect breast cancer at an early stage. When followed up with appropriate diagnosis and treatment, the survival rate is nearly 98%. New evidence demonstrates that women at increased risk of breast cancer may benefit from additional screening technologies. Certain women may benefit from earlier initiation of screening including shorter screening intervals and the addition of other screening modalities such as ultrasound and magnetic resonance imaging (MRI).
The addition of Hologic’s C-View™ software to our screening equipment coupled with its dose reducing capability realizes all the benefits of tomosynthesis at doses comparable to conventional 2D mammography. This technology will be coupled with Windsong’s unique personalized breast screening algorithm which will allow us to offer your patients the highest performance technology with the most comprehensive screening.
Windsong has been utilizing tomosynthesis since its FDA approval in 2011. Windsong Radiologists have utilized this unparalleled duration of experience with tomosynthesis to become the best trained in this new technology. With the added benefit of C-view (synthesized 2D mammogram) with the tomosynthesis, Windsong has taken the needed time to become comfortable with this technology to decrease the false positive rate that can occur with any exam. We feel confident that Hologic’s
C-View™ with tomosynthesis and its lower radiation dose is the best mammogram for a majority of women in which a mammographic exam is indicated.
The new algorithm designed specifically by Windsong will differentiate screening needs based upon cancer risk accordingly. This algorithm will assist our referring providers with clear determination of what screening tests are appropriate for their individual patients.
All age-appropriate women are recommended to receive a C-View study which is a synthesized mammo/tomo (3D).
Those that are at an intermediate risk (11-19% lifetime risk) and have dense breast tissue are recommended to have the C-view study and screening ultrasound. Those women who are at high risk (have a greater than 20% or higher lifetime risk) are recommended to have the C-view study and a breast MRI.
OUTPATIENT TREATMENT OF PELVIC CONGESTION SYNDROME AVAILABLE AT WINDSONG
Causes of chronic pelvic pain are varied, but are often associated with pelvic varicose veins. It is also known as pelvic congestion syndrome (PCS) when other etiologies are not found such as uterine/ovarian abnormalities.
PCS is similar to varicose veins in the legs. Both result when the valves in the vein become weakened and do not close properly. This allows blood to flow backwards and pool in the vein causing pressure and bulging veins. Since this worsens with sitting/standing (due to backup from gravity, symptoms often worsen throughout the day.
- Common signs of PCS:
- Leg/pelvic/buttock pain, aching or cramping
- Pelvic discomfort and fullness throughout the month
- Pelvic bloating
- Pain/aching with and/or after intercourse
- Pelvic/abdominal tenderness
Symptoms may worsen after standing for long periods of time, following intercourse, during menstrual periods, during or following pregnancy.
If your patients present with irritable bladder, varicose veins on vulva, buttocks or thigh or leg swelling and varicose veins, they may be suffering from pelvic congestion syndrome. PCS can affect anyone but is most common between the ages of 30 and 50 years old. Other factors that may increase risk include history of varicose veins, two or more pregnancies, polycystic ovaries, or hormonal dysfunction.
Windsong’s Interventional Radiology clinic evaluates PCS with a specialized ultrasound which is performed to evaluate pelvic veins. If treatment is warranted, our interventional team can perform an outpatient minimally invasive procedure using image guidance in our clinic at our Williamsville location. This procedure is carried out under local anesthesia with intravenous sedation to assure patient comfort. A small catheter is placed into the vein to perform a diagnostic venogram. Blood supply to the pelvic varices is then blocked by the use of surgical plugs and or embolic agents. The blood is then rerouted from the damaged veins into healthy veins. After the procedure, patients can return home or to work immediately. There is an 85 to 95% success rate in pain reduction following this procedure. To learn more, please contact the IR team at 716.929.9484.
Williamsville, December 26, 2016 – Windsong is excited to announce that it is now offering a new FDA approved treatment for prostate cancer. Xofigo® (Radium 223 dichloride) is a new therapy used to treat prostate cancer that is resistant to other medical and surgical treatments that seek to lower testosterone levels in patients whose disease has spread to the bones.
Patients meeting certain criteria including acceptable white blood cell and platelet counts, along with proven metastatic bone disease, may be eligible for up to 6 monthly infusions of this treatment. The monthly administration is very simple, and side effects are minimal. Dr. Thomas Summers, president of Windsong said, “We are proud to offer a convenient new site in Williamsville for this treatment, which up until this point was only available at Roswell Park.”
According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer. This year alone, nearly 230,000 men will be diagnosed with the cancer and nearly 29,500 will die from the disease in the U.S. If prostate cancer starts to spread to other areas of the body, it most commonly goes to the bones which results in rapid tumor growth. The alpha particle-emitting isotope radium-223, mimics calcium and targets bone metastases. It is reported that patients who receive XOFIGO live longer, and demonstrate a delay in their first bone- related symptom or event.
This cutting edge treatment option is just one more demonstration of Windsong’s commitment to bringing the latest medicines to patients. For more information, please contact Laurie Fuller at
716.631.2500, ext. 2152 or go to xofigo-us.com.